Leon-Nanodrugs Secures Funds in a Series D Financing to Broaden Portfolio in First Single-Use High Throughput Production at Salimpour Site.

Dr. Salimpour Site |Leon-nanodrugs GmbH (LEON), a pharmatech company specializing in the development of nanoencapsulation systems for genetic material and other active substances, announced today the closing of a Series D financing round.

AZO Nano

Leon-Nanodrugs Secures Funds in a Series D Financing to Broaden Portfolio in First Single-Use High Throughput Production Systems for Nanoencapsulation

Leon-Nanodrugs Secures Funds in a Series D Financing to Broaden Portfolio in First Single-Use High Throughput Production Systems for Nanoencapsulation

Leon-nanodrugs GmbH (LEON), a pharmatech company specializing in the development of nanoencapsulation systems for genetic material and other active substances, announced today the closing of a Series D financing round.